New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma.
2/5 보강
TL;DR
As the therapeutic landscape for Hodgkin lymphoma evolves, studies examining the impact of new treatments on disparities are needed to ensure that treatment advances benefit all populations equitably.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: Hodgkin lymphoma differs by age, race and ethnicity, socioeconomic status, insurance, and treatment location
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Inequities are evident across the cancer care continuum, from timely diagnosis and treatment initiation and clinical trial access, to posttreatment survivorship care. As the therapeutic landscape for Hodgkin lymphoma evolves, studies examining the impact of new treatments on disparities are needed to ensure that treatment advances benefit all populations equitably.
OpenAlex 토픽 ·
Lymphoma Diagnosis and Treatment
CNS Lymphoma Diagnosis and Treatment
Head and Neck Cancer Studies
As the therapeutic landscape for Hodgkin lymphoma evolves, studies examining the impact of new treatments on disparities are needed to ensure that treatment advances benefit all populations equitably.
APA
Katia M. Crisler, Mallorie B. Heneghan, Justine M. Kahn (2026). New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma.. Hematology/oncology clinics of North America, 40(2), 247-256. https://doi.org/10.1016/j.hoc.2025.12.007
MLA
Katia M. Crisler, et al.. "New Developments in Hodgkin's Lymphoma: Outcomes and Disparities in Classic Hodgkin Lymphoma.." Hematology/oncology clinics of North America, vol. 40, no. 2, 2026, pp. 247-256.
PMID
41667302 ↗
Abstract 한글 요약
Despite continued advances, survival among patients with Hodgkin lymphoma differs by age, race and ethnicity, socioeconomic status, insurance, and treatment location. Inequities are evident across the cancer care continuum, from timely diagnosis and treatment initiation and clinical trial access, to posttreatment survivorship care. As the therapeutic landscape for Hodgkin lymphoma evolves, studies examining the impact of new treatments on disparities are needed to ensure that treatment advances benefit all populations equitably.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.